B Pégourié-Bandelier

No ORCID on file · 1 paper in corpus
rct 1994
Cancer ·doi:10.1002/1097-0142(19940615)73:12<3073::aid-cncr2820731228>3.0.co;2-#

BACKGROUND: Treatment of myelodysplastic syndromes (MDSs) remains unsatisfactory. A limited number of reports provide contradictory information on whether danazol, a synthetic androgen, may be useful in patients with MDS. METHODS: Between …